A listing of Spinal Cord Injuries medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
MT-3921 is an investigational monoclonal antibody therapy for patients with severe (AIS grade A-C) traumatic cervical spinal cord injury (SCIs). This study aims to compare the efficacy of MT-3921 to a placebo with regard to improving patients sensory and motor function and overall quality of life. Additionally this study aims …